OpenLegislation

Part 6 Transitional provision in relation to the Paediatric RegulationF1

  1. 41Transitional provision in relation to applications made to EMA before IP completion day under the Paediatric Regulation
  2. 41ATransitional provision in relation to global marketing authorisations under the 2001 Directive

Annotations

Textual amendments

F1

Sch. 33A inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 7 (as amended by S.I. 2020/1488, reg. 1, Sch. 2 para. 193); 2020 c. 1, Sch. 5 para. 1(1)